CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Radiosurgeryradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00573872
NCT00573872N/ACompleted
CompareCT.gov

A Phase II Study of Spinal Radiosurgery

University of Alabama at Birmingham·interventional·Posted Dec 14, 2007·Updated Dec 5, 2017

In Brief

A clinical study evaluating Radiosurgery for Neoplasm and Arteriovenous Malformations. Completed, enrolled 43 participants across 1 site.

Detailed Summary

Phase I of the study (motion and quality assurance \[QA\] study) is being used to determine intrafraction target motion and define quality assurance procedures for single fraction spinal radiosurgery. The Phase II portion of the study is being used to estimate the palliative response (pain or relief of neurologic symptoms) and local control for single fraction radiosurgery delivered with TomoTherapy and to assess the acute and late toxicity of spinal radiosurgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeoplasm, Arteriovenous Malformations
CountriesUnited States
CollaboratorsHealth Services Foundation, The Kirklin Clinic at Acton Road

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 14, 2007
Enrollment StartApr 1, 2005
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11.4 yearsPosted 18.6 years ago

Interventions

Radiosurgeryradiation

Phase I: 20-25 Gy in 5 fractions Phase II: 9-24 GY in 1 fraction